Filters
Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosim...
Press Release, Product
Hikma announces strong medium-term Group guidance ahead of its US site visit
Press Release, Corporate
Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits
Press Release, Corporate
S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable
Press Release, Corporate
Hikma reiterates full year guidance following good start to the year
Press Release, Corporate
Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France
Insight, Life at Hikma
Hikma acquires Novugen’s FDA-approved ANDA for trametinib
Press Release, Product
Hikma signs exclusive licensing agreement with pharma& to bring innovative oncology treatment to MENA
Press Release, Business Development
Hikma launches Cisatracurium Besylate Injection, USP in the US
Press Release, Product
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Press Release, Product
Developing our pipeline in growing therapeutic areas
Story, Corporate
Expanding our patient reach across our markets
Story, Corporate
Leveraging our role as a leading healthcare provider in MENA
Story, Corporate